Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-030683

Chief Business Officer sold 50,000 shares at $26.06 ($1,303,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2022-09-07 Sale −50,000 $26.06 $1,303,000 49,544 D
Open-market sales · 50,000 sh · avg $26.06 · $1,303,000
Loading xslF345X03/doc4.xml…